The start-up company NISI (HK) Limited is currently developing a miniature surgical robot that can be inserted though natural openings in the body and only unfolds inside the abdomen. To achieve this goal, the engineers are pushing components to their limits and beyond.
In the world of medtech, there are many astonishing new developments these days. The world of surgical robots could soon be disrupted: In summer 2018, the Hong Kong-based startup NISI announced that they have successfully performed a series of gynecological operations on live pigs. This may not sound like anything special at first, however: The essence is that the surgeons used a small robot that had been inserted rectally. This is a world’s first in medical history, according to the company.
NISI was founded in 2012 and works with the universities of Hong Kong and Cambridge to develop a robotic system that enables complex, minimal-invasive surgeries in the abdominal and pelvic area without leaving visible scars. “We want to become the world’s leading expert in non-invasive surgical robotic technology,” says Dr. Corinna Ockenfeld at NISI. The successful surgeries in the summer of 2018 have given the medtech start-up a lot of momentum. Initial surgeries on humans are planned for 2021.